24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
A comprehensive guide to Ilumya (tildrakizumab-asmn) for managing moderate to severe plaque psoriasis in India, covering dosage, side effects, and precautions.

Plaque psoriasis is a chronic autoimmune condition that affects millions worldwide, including many in India. It manifests as thick, scaly, and often itchy or painful patches of skin, known as plaques. While it commonly appears on the elbows, knees, lower back, and scalp, it can occur anywhere on the body. For adults struggling with moderate to severe plaque psoriasis, especially those who haven't found relief with other treatments like phototherapy or systemic therapy, a newer biologic medication called Ilumya (tildrakizumab-asmn) offers a potential avenue for management. This guide aims to provide comprehensive information about Ilumya, tailored for Indian patients, covering its mechanism of action, dosage, potential side effects, and what to expect during treatment.
Plaque psoriasis is an autoimmune disorder where the body's immune system mistakenly attacks healthy skin cells. This leads to an accelerated life cycle of skin cells, causing them to build up rapidly on the skin's surface. This buildup forms the characteristic plaques β raised, red areas covered with silvery scales. These plaques can cause discomfort, itching, and sometimes pain, significantly impacting a person's quality of life. The condition is chronic, meaning it requires long-term management.
Ilumya is a biologic medication, meaning it is derived from living organisms. Its active ingredient, tildrakizumab-asmn, specifically targets and blocks a protein called interleukin-23 (IL-23). IL-23 plays a crucial role in the immune system's inflammatory response, particularly in conditions like psoriasis. By inhibiting IL-23, Ilumya helps to reduce the inflammation that drives plaque psoriasis, thereby slowing down the rapid skin cell turnover and decreasing the formation of plaques. This targeted approach aims to provide relief from the symptoms of psoriasis.
Ilumya is prescribed for adults who have moderate to severe plaque psoriasis. It is typically considered for individuals who could benefit from systemic therapy (treatment that affects the entire body) or phototherapy (light therapy). Your dermatologist will assess the severity of your psoriasis and your overall health to determine if Ilumya is an appropriate treatment option for you.
Ilumya is administered as an injection under the skin (subcutaneous injection). In India, like in other countries, it is typically given by a healthcare professional at a doctor's office, clinic, or hospital. The standard dosing regimen is as follows:
The injection can be given in areas such as the abdomen, at least 2 inches away from the belly button. Your healthcare provider will ensure the injection site has clear, healthy skin, free from tenderness or bruising. It is crucial to follow the prescribed dosing schedule to maintain the effectiveness of the treatment.
Like all medications, Ilumya can cause side effects. While not everyone experiences them, it's important to be aware of the possibilities. The side effects can range from mild to serious.
While less common, serious side effects can occur. These may include:
It is essential to discuss any concerns about side effects with your doctor. They can help manage these effects and determine if continuing treatment with Ilumya is appropriate.
Before starting Ilumya, inform your doctor about your complete medical history, including:
Your doctor may perform certain tests before and during treatment to monitor your health and check for any potential issues.
Managing plaque psoriasis involves a combination of medical treatment, lifestyle adjustments, and emotional well-being. While Ilumya can significantly improve skin symptoms, maintaining a healthy lifestyle can complement the treatment.
It is important to consult your doctor or dermatologist if:
A1: Ilumya is a treatment that helps manage the symptoms of plaque psoriasis. It is not considered a permanent cure, as psoriasis is a chronic condition. Continuous treatment is often necessary to maintain symptom control.
A2: Ilumya is approved for moderate to severe plaque psoriasis in adults. It may be used off-label for other conditions, but this should only be done under the strict guidance of a doctor.
A3: The cost of Ilumya can vary depending on factors such as the pharmacy, your location, and any insurance coverage or patient assistance programs available. It is advisable to discuss the cost and potential financial assistance options with your doctor or pharmacist.
A4: Yes, there are other treatment options for plaque psoriasis, including topical medications, phototherapy, other biologic agents, and oral medications. Your dermatologist will discuss the most suitable options based on your individual needs and the severity of your condition.
A5: You must inform your doctor about all your existing health conditions before starting Ilumya. Your doctor will assess the risks and benefits based on your specific health profile.
Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026